论文部分内容阅读
在1984年杭州召开再障生血片临床鉴定会,确认该药治疗再障有率效达71.2％的基础上,为了进一步提高疗效,探索不同类型治疗再障的新途径,经浙医大附一院等个七单位共同协作研究,共治疗观察再生障碍性贫血548例(表1).现将疗效分析于下.
In 1984, Hangzhou held reexamination blood tablets clinical identification will confirm the drug treatment of aplastic anemia rate of 71.2%, based on the further improvement of the efficacy of exploration of different types of treatment of aplastic anemia on the basis of the Zhejiang University Affiliated Hospital And other seven units collaborative research, a total of 548 cases of aplastic anemia observed (Table 1). The efficacy analysis in the next.